Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis - Evidence for a pathogenetic role of B cells

被引:183
作者
De Vita, S [1 ]
Zaja, F [1 ]
Sacco, S [1 ]
De Candia, A [1 ]
Fanin, R [1 ]
Ferraccioli, G [1 ]
机构
[1] Univ Udine, Dept Rheumatol, I-33100 Udine, Italy
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 08期
关键词
D O I
10.1002/art.10467
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The pathogenetic role of B cells in rheumatoid arthritis (RA) is under debate, but it is currently believed to be marginal. The availability of selective anti-B cell treatment provides a unique opportunity to clarify this. issue. This study was undertaken to investigate the effects of B cell blockade in the treatment of refractory RA, and to evaluate the implications with regard to the role of B cells in the disease. Methods. Five female patients with active, evolving erosive RA were treated with rituximab, an antiCD20 chimeric monoclonal antibody. All 5 patients had been nonresponders to combination therapy with methotrexate plus cyclosporin A. Two of the 5 had also failed to respond to anti-tumor necrosis factor a therapy. All of these treatments were discontinued I month before institution of anti-CD20 therapy. Results. Marked clinical improvement was observed in 2 patients (American College of Rheumatology 70% response [ACR70] and ACR50, respectively), starting at the end of the second month after institution of anti-CD20 therapy (month 2) and lasting until month 10 in I patient (articular relapse) and month 12 in the other (last followup). ACR20 response was observed in 2 additional patients, lasting until month 5 and month 7, respectively (articular relapse in both). Decrease or normalization of serum C-reactive protein and rheumatoid factor levels were observed in these patients. In contrast, patient 3 had no response to the treatment. RA synovitis and evolving erosive damage were decreased in patients exhibiting a major response, as demonstrated by imaging studies. Conclusion. Our finding of the clinical efficacy of selective B cell blockade indicates that B cells play a critical role in rheumatoid synovitis, at least in a subset of patients. Qualitative or quantitative differences in B cell commitment in RA pathobiology might have a function in the different responses observed.
引用
收藏
页码:2029 / 2033
页数:5
相关论文
共 14 条
  • [1] ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
  • [2] Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
    Berinstein, NL
    Grillo-Lopez, AJ
    White, CA
    Bence-Bruckler, I
    Maloney, D
    Czuczman, M
    Green, D
    Rosenberg, J
    McLaughlin, P
    Shen, D
    [J]. ANNALS OF ONCOLOGY, 1998, 9 (09) : 995 - 1001
  • [3] Mechanisms of disease: Cytokine pathways and joint inflammation in rheumatoid arthritis.
    Choy, EHS
    Panayi, GS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (12) : 907 - 916
  • [4] Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren's syndrome
    DeVita, S
    Boiocchi, M
    Sorrentino, D
    Carbone, A
    Avellini, C
    Dolcetti, R
    Marzotto, A
    Gloghini, A
    Bartoli, E
    Beltrami, CA
    Ferraccioli, G
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (02): : 318 - 331
  • [5] Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes
    Edwards, JCW
    Cambridge, G
    [J]. RHEUMATOLOGY, 2001, 40 (02) : 205 - 211
  • [6] Rituximab (IDEC-C2B8): Validation of a sensitive enzyme-linked immunoassay applied to a clinical pharmacokinetic study
    Iacona, I
    Lazzarino, M
    Avanzini, MA
    Rupolo, M
    Arcaini, L
    Astori, C
    Lunghi, F
    Orlandi, E
    Morra, E
    Zagonel, V
    Regazzi, MB
    [J]. THERAPEUTIC DRUG MONITORING, 2000, 22 (03) : 295 - 301
  • [7] B cells in rheumatoid arthritis
    Kim, HJ
    Berek, C
    [J]. ARTHRITIS RESEARCH, 2000, 2 (02) : 126 - 131
  • [8] Maloney DG, 1997, BLOOD, V90, P2188
  • [9] REFF ME, 1994, BLOOD, V83, P435
  • [10] T cell activation in rheumatoid synovium is B cell dependent
    Takemura, S
    Klimiuk, PA
    Braun, A
    Goronzy, JJ
    Weyand, CM
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (08) : 4710 - 4718